Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
2
×
san francisco blog main
san francisco top stories
2
×
sanofi
2
×
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biogen
biotech
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
cholesterol
covid-19
crispr
data
deals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
What
announced
ceo
2
×
medicines
aces
acquisitions
big
bio
cholesterol
collabs
covid
daniel
deal
drug
flexible
gilead
gilead’s
help
inclisiran
introduce
ipo
key
lowering
meant
medco
medicine
month
nasdaq
open
o’day
passed
plans
pricing
roundup
sciences
taken
test
transformative
twice
week
year
Language
unset
Current search:
sanofi
×
ceo
×
" san francisco top stories "
×
" new york top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing